NIRDEZMY Trademark

Trademark Overview

On Friday, September 10, 2021, a trademark application was filed for NIRDEZMY with the United States Patent and Trademark Office. The USPTO has given the NIRDEZMY trademark a serial number of 97022045. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, August 16, 2024. This trademark is owned by SpringWorks Therapeutics Operating Company, Inc.. The NIRDEZMY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncology, tumors, and multiple myeloma; small molecule therapeutic preparations for the treatment of oncology, tumors, and multiple myeloma
nirdezmy

General Information

Serial Number97022045
Word MarkNIRDEZMY
Filing DateFriday, September 10, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, August 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 4, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncology, tumors, and multiple myeloma; small molecule therapeutic preparations for the treatment of oncology, tumors, and multiple myeloma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSpringWorks Therapeutics Operating Company, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressStamford, CT 06902
Party NameSpringWorks Therapeutics Operating Company, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStamford, CT 06902

Trademark Events

Event DateEvent Description
Tuesday, September 14, 2021NEW APPLICATION ENTERED
Tuesday, October 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 14, 2022ASSIGNED TO EXAMINER
Thursday, June 16, 2022NON-FINAL ACTION WRITTEN
Thursday, June 16, 2022NON-FINAL ACTION E-MAILED
Thursday, June 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 9, 2023ASSIGNED TO LIE
Tuesday, January 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 8, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 8, 2023NON-FINAL ACTION E-MAILED
Wednesday, February 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 8, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, May 8, 2023EXAMINERS AMENDMENT E-MAILED
Monday, May 8, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 8, 2023EXAMINER'S AMENDMENT ENTERED
Saturday, May 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 4, 2023PUBLISHED FOR OPPOSITION
Saturday, May 27, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 14, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 20, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 20, 2023SOU EXTENSION 1 FILED
Wednesday, December 20, 2023SOU EXTENSION 1 GRANTED
Friday, December 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 16, 2024SOU EXTENSION 2 FILED
Friday, August 16, 2024SOU EXTENSION 2 GRANTED

Related Keywords

nirdezmy multiple myeloma oncology tumors treatment preparations therapeutic molecule small pharmaceutical